AZD4041

DRUG4 trials

Sponsors

AstraZeneca

Conditions

Opioid Use DisorderOpioid Use Disorder (OUD)Smoking Cessation

Phase 1

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4041 in Healthy Volunteers

CompletedNCT04076540

AstraZenecaSmoking Cessation

Start: 2019-10-03End: 2022-01-02Updated: 2024-07-17

A Safety Study of AZD4041 in Healthy Participants

CompletedNCT05233085

AstraZenecaOpioid Use Disorder (OUD)

Start: 2021-12-17End: 2022-06-07Updated: 2023-11-27

A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.

CompletedNCT05587998

AstraZenecaOpioid Use Disorder

Start: 2022-08-31End: 2023-05-25Updated: 2024-11-15

Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

TerminatedNCT06406400

AstraZenecaOpioid Use Disorder

Start: 2024-05-13End: 2024-07-31Updated: 2025-03-26